ProductsEarlyTect (R) is the promise of Genomictree to keep your tomorrow healthy through early detection of cancer.
Qualitative detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients
Qualitative detection of genetic and epigenetic markers for diagnostics of recurrence in patients previously diagnosed with bladder cancer
Cancer Type: Bladder Cancer (Early Detection)
Subject: Hematuria patients
Biomarker: PENK methylation
Specimen: Urine DNA (10mL)
Patent Granted: South Korea, US, Europe, China and Japan